Coronary Heart Disease: Have We Reached a Plateau in Primary Prevention?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Microalbuminuria and mortality in individuals with coronary heart disease: A meta-analysis of a prospective study.Indian heart journal
   Pooled it
2. Clinical study on the combined use of cardiovascular agents and statins in the treatment of coronary heart disease.Pakistan journal of medical sciences · 2026
   Article
3. Predictive Value of Cardiopulmonary Exercise Testing Parameters in Patients under Percutaneous Coronary Intervention with High Pulse Pressure.Reviews in cardiovascular medicine · 2025
   Article
4. Coronary heart disease increases the risk of perioperative ischemic stroke after noncardiac surgery: A retrospective cohort study.CNS neuroscience & therapeutics · 2024
   Article
5. Clinical applications of polygenic risk score for coronary artery disease through the life course.Atherosclerosis · 2023
   Review
6. Integrated analysis of miRNA-mRNA regulatory network and functional verification of miR-338-3p in coronary heart disease.Functional & integrative genomics · 2022
   Article
7. Protective Effects of Circulating TIMP3 on Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study.Journal of cardiovascular development and disease · 2022
   Article
8. The therapeutic effect and targets of cellulose polysaccharide on coronary heart disease (CHD) and the construction of a prognostic signature based on network pharmacology.Frontiers in nutrition · 2022
   Article
9. LncRNA Landscape of Coronary Atherosclerosis Reveals Differentially Expressed LncRNAs in Proliferation and Migration of Coronary Artery Smooth Muscle Cells.Frontiers in cell and developmental biology · 2021
   Article

Corrections and comments

• Comment on
  Coronary Disease Surveillance in the Community: Angiography and Revascularization.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as